Objective To investigate the effect of matrine on multidrug resistance of Eca-100/VCR cells. Methods Methyl thiazolyl tetrazolium assay was used to assess the cytotoxic activity of matrine to Eca-109/VCR cells and the sensitivity of cells to Vincristine (VCR). Then Eca-109/VCR cells were divided into four groups: control group, matrine group, VCR group and matrine combined with VCR group. Immunofluorescence staining was used to detect P-gp protein expression. Western blot was used to detect MRP1, P-gp, Beclin 1, p62(SQSTM1), LC3, p-mTOR, p-Akt and p-p70S6K protein expression. MDR1 mRNA expression was detected by RT-qPCR. Transmission electron microscopy was used to detect the ultra structural changes. Results Matrine could reverse the resistance of Eca-109/VCR cells to VCR with a reversal index of 3.52. Compared with the other groups, the expression of LC3-II, Beclin 1 increased while P-gp, MRP1, p62(SQSTM1), p-mTOR, p-Akt and p-p70S6K significantly decreased in matrine+VCR group (P<0.05). The expression of MDR1 mRNA decreased in Eca-109/VCR cells treated with matrine, VCR or their combination. The number of autophagic vacuoles in Eca-109/VCR cells increased after matrine treatment. Conclusion Matrine has anticancer and anti multidrug resistance functions in Eca-100/VCR cells, and it may be produced by promoting autophagy which mediated through PI3K/Akt/mTOR signaling pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.